Abstract 4927: Exarafenib (KIN-2787) is a Potent, Selective Pan-Raf Inhibitor with Activity in Preclinical Models of BRAF Class II/III Mutant and NRAS Mutant Melanoma

Tim S. Wang,Catherine Lee,Paul Severson,Robert J. Pelham,Richard Williams,Nichol L. G. Miller

Cancer Research（2023）

Cited 0|Views0
No score
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined